Rahimić, J.; Alibegović, E.; Lekić, L.; Boras, M.M.; Džidić-Krivić, A.; Farhat, E.K.; Sher, E.K.
Evaluating Vancomycin Monotherapy and Dual Therapy with Nifuroxazide for Medium–Severe Clostridioides Difficile Infection. Antibiotics 2025, 14, 400.
https://doi.org/10.3390/antibiotics14040400
AMA Style
Rahimić J, Alibegović E, Lekić L, Boras MM, Džidić-Krivić A, Farhat EK, Sher EK.
Evaluating Vancomycin Monotherapy and Dual Therapy with Nifuroxazide for Medium–Severe Clostridioides Difficile Infection. Antibiotics. 2025; 14(4):400.
https://doi.org/10.3390/antibiotics14040400
Chicago/Turabian Style
Rahimić, Jasna, Ervin Alibegović, Lana Lekić, Marijana Marković Boras, Amina Džidić-Krivić, Esma Karahmet Farhat, and Emina Karahmet Sher.
2025. "Evaluating Vancomycin Monotherapy and Dual Therapy with Nifuroxazide for Medium–Severe Clostridioides Difficile Infection" Antibiotics 14, no. 4: 400.
https://doi.org/10.3390/antibiotics14040400
APA Style
Rahimić, J., Alibegović, E., Lekić, L., Boras, M. M., Džidić-Krivić, A., Farhat, E. K., & Sher, E. K.
(2025). Evaluating Vancomycin Monotherapy and Dual Therapy with Nifuroxazide for Medium–Severe Clostridioides Difficile Infection. Antibiotics, 14(4), 400.
https://doi.org/10.3390/antibiotics14040400
